Cullinan Oncology

About Cullinan Oncology

Cullinan Oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. Sourced from the Cullinan dry lab as well as external collaborators, Cullinan’s assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.

YEAR FOUNDED:
2017

LEADERSHIP:
Co-Founder and CSO: Patrick Baeuerle, PhD
CEO: Owen Hughes
CSO: Leigh Zawel, PhD

APPROACH
Please click here for Cullinan Oncology's approach.

8 articles with Cullinan Oncology